Nam-Gu Her
Chief Executive Officer Aimed Bio
Nam-Gu Her, PhD, is the Chief Executive Officer of Aimed Bio Inc., a Seoul-based biotechnology company focused on developing antibody-based therapeutics for brain diseases and cancer. He previously served as Head of R&D at Aimed Bio and has held research leadership roles including Principal Scientist and team leader at Samsung Medical Center. Dr. Her has been principal investigator on numerous competitive research grants and holds a B.S., M.S., and PhD in Life Sciences and Biotechnology from Korea University, with postdoctoral training in the United States.
Seminars
Wednesday 10th June 2026
Panel Discussion: Hearing Korean ADC Developers’ Perspectives on ADC Development to Accelerate Innovation & Establish South Korea as a Hub of ADC Development
9:00 am
- Honing insights from ADC pioneers in South Korea on cutting-edge research and lessons learned that are driving innovations
- Understanding how partnerships with pharma are accelerating ADC development
- Analyzing the future direction of ADC development to strengthen Korea’s global leadership in next-generation ADC therapeutics
